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Abstract 
Background. The effectiveness of therapy for an acute coronary syndrome (ACS) is 
dependent on patients’ quick decision to seek treatment. We surveyed level of knowledge 
about heart disease and self-perceived risk for a future acute myocardial infarction (AMI) 
in patients with documented ischemic heart disease.  
Methods.  Patients (N= 3522) were mean age 67 years, 68% male and all had a history of 
AMI or invasive cardiac procedure for ischemic heart disease. Data were gathered using a 
26-item instrument focusing on ACS symptoms and appropriate steps to seeking 
treatment. Patients were asked to identify their level of perceived risk for a future AMI.  
Results.  Forty-six percent of patients had low knowledge levels (i.e., <70% correct). The 
mean score was 71%. Higher knowledge scores were significantly related to female 
gender, younger age, higher education, participation in cardiac rehabilitation, and 
receiving care by a cardiologist rather than an internist or general practitioner. Clinical 
history (e.g., AMI or cardiac surgery) was not a significant predictor of knowledge. The 
majority (57%) identified themselves as being at higher risk for a future AMI compared 
to an age-matched individual without heart disease with one exception. Namely, patients 
who had coronary artery bypass surgery felt significantly less vulnerable for a future 
AMI than other individuals of the same age. 
Conclusions.  Even following diagnosis of ACS and numerous interactions with 
physicians and other healthcare professionals, knowledge about ACS symptoms and 
treatment on the part of patients with cardiac disease remains poor. Patients require 
continued reinforcement about the nature of cardiac symptoms, the benefits of early 
treatment, and their risk status.
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Although knowledge about heart disease and its symptoms is not sufficient to reduce 
delay in seeking treatment, it is necessary for patients so that they can quickly identify 
symptoms of acute coronary syndrome (ACS) and take prompt action to seek care. A 
decision to seek care quickly is critical to minimizing morbidity and mortality in ACS.1-4 
In fact, the goal for instituting definitive treatment in an evolving acute myocardial 
infarction (AMI) is one hour from symptom onset,5 with survival rates improved by up to 
50% if reperfusion is achieved within one hour.5 Delaying treatment even by 30 minutes 
reduces average life expectancy by 1 year,6 underscoring the importance of patients 
knowing the nature of ACS symptoms, and seeking care quickly. The median time from 
symptom onset to admission to the hospital is 2.5 to 3.0 hours, and this delay has not 
changed significantly for the past decade, despite extensive community education 
programs.7,8 
 Barriers to seeking appropriate care quickly are both cognitive and emotional.9-11 
If patients do not know symptoms of ACS such as nausea, jaw pain and syncope, as well 
as the more commonly associated symptoms such as chest and left arm pain, they will not 
label their physical symptoms appropriately. If they do not perceive themselves as 
vulnerable or at risk for experiencing AMI, they will seek another explanation for their 
new symptoms. Thus, a lack of knowledge about cardiac symptoms and low perception 
of risk can contribute to the prolonged delay seen in many cases of ACS.  It is important 
to determine what patients with coronary heart disease know about the symptoms of their 
disease and the appropriate course of action to take, as well as their level of perceived 
risk for a future cardiac event in order to provide appropriate information during the brief 
encounter available to most physicians and to design appropriate educational programs. 
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Therefore, we conducted a study to assess level of knowledge about heart disease and 
ACS symptoms in patients with documented ischemic heart disease who were at high risk 
for a future cardiac event. We also identified the characteristics of those patients who had 
inadequate knowledge about cardiac symptoms and treatment options, as well as those 
who identified themselves as having a low risk for a future ACS event. 
Methods 
 Following review and approval of the study by the Institutional Review Boards at 
the participating institutions, we enrolled 3,522 patients with diagnosed ischemic heart 
disease into a randomized controlled trial.  The study design has been described 
previously,12 but briefly consisted of randomization to a single educational session 
delivered face-to-face by a nurse or to a care-as-usual control group. The hypothesis of 
the trial was that the experimental intervention would decrease pre-hospital delay time 
(from ACS symptom onset to hospital admission), and increase ambulance use and 
appropriate use of aspirin. The current analysis focuses on the knowledge of cardiac 
patients and their perceived risk for a future AMI measured prior to group assignment.  
Sample 
 Patients were recruited from participating centers’ cardiovascular in-patient units 
and coronary catheterization laboratories and from a variety of out-patient cardiac clinics, 
cardiac rehabilitation programs and community medical practices in the United States, 
Australia and New Zealand. When allowed by the appropriate Institutional Review 
Boards, eligible patients were sent a letter signed by their private physician inviting them 
to participate and giving them a toll-free number to call. Subjects were eligible if they 
had a confirmed diagnosis of ischemic heart disease and if they lived independently (i.e., 
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not in an institutional setting). No attempt was made to categorize patients as being either 
acute or chronic since complete medical records were not always available at the time of 
enrollment. The diagnosis of ischemic heart disease was confirmed by medical record 
review, either of hospital medical records in the case of those patients currently or 
recently hospitalized, or records maintained in the offices of private physicians if patients 
were referred by a medical practice. Subjects were excluded if they had:  1) untreated 
malignancy or neurological disorder with impaired cognition, 2) an inability to read or 
understand English, and 3) a major and uncorrected hearing loss. The latter two criteria 
were assessed by the research assistant in the first face-to-face meeting. 
 All participants gave informed consent prior to randomization. Baseline data were 
collected by medical record review, patient interview, and written questionnaires. 
Instruments were administered in a place convenient to the patient (e.g., out-patient 
clinic, physician’s office, or patient’s home). Data collected from the medical record and 
interview included sociodemographic information, clinical history, and the specialty of 
the treating physician. Data regarding patients’ knowledge about cardiovascular disease 
and ACS symptoms, as well as their perceived vulnerability for a future AMI, were 
collected using a structured questionnaire. Interviewers were registered nurses with 
graduate degrees and special expertise in cardiac care. Project directors at each study site 
audited 10% of all enrollments. 
Instruments 
 Knowledge was measured by the Knowledge Scale of the ACS Response Index, a 
modification of the instrument developed for the Rapid Early Reaction for Coronary 
Treatment (REACT) study to measure knowledge, attitudes and beliefs about coronary 
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heart disease.13 Content validity, discriminant validity, and internal consistency reliability 
were assessed and demonstrated for scales measuring knowledge, attitudes and beliefs 
using established methods.14 The knowledge scale consists of 21items in which patients 
were asked to identify possible AMI symptoms from a list of 15 correct and 6 incorrect 
symptoms. Patients were also asked to respond to 5 additional items about heart disease 
that were framed as statements with true/false responses. Examples are “Hospitals have 
drugs that reduce the damage done when a heart attack occurs” and “Heart disease is the 
most common cause of death in women in the United States”. The instrument was self-
administered. Internal reliability of the Knowledge Scale was measured by Cronbach’s 
alpha and was judged adequate at .76.  
 Perceived vulnerability to a future ACS event was measured by the following 
question: “Compared to other people your age, how likely do you think it is that you 
could have a heart attack in the next five years?” Participants were asked to respond to 
the statement using a 5 point Likert scale that ranged from 1 (much less likely) to 5 
(much more likely).   
Statistical Analysis 
 SPSS version 15.0 for Windows (Chicago, Illinois) was used for data analysis, 
and accuracy of data entry was checked by systematic audits, as well as by examining the 
data in order to identify outliers and missing data. The chi-square test was used to 
examine categorical data, and the independent t-test was used to test continuous data in 
relation to the high and low knowledge groups and the high and low perceived risk 
groups. There was no significant difference in knowledge or risk perception scores 
between patients recruited from the U.S. compared to patients from Australia or New 
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Zealand so the sample was combined for all analyses. Logistic regression analyses were 
performed to identify predictors of high knowledge (> 70% correct on the Knowledge 
Scale of the ACS Response Index, with 70% set as a common demarcation of failure on 
educational tests) and high perceived risk group membership (based on a response that 
the patient perceived the risk of a heart attack in the next 5 years as greater than or equal 
to that of an age-matched healthy control). Variables showing marginal association with 
p < 0.25 in univariate analyses were forwarded to the regression analysis.  The Hosmer-
Lemeshow statistic was used to evaluate goodness-of-fit of the model. Except where 
otherwise specified, the level of significance for statistical analyses was set at p< .05. 
Results 
 On average, patients were 67±11 years of age, 68% were male, and all had 
documented ischemic heart disease. See Table 1.  Despite having a history of coronary 
heart disease, 44% of patients had significant gaps in knowledge about ACS, as 
documented by scores of less than 70% on the Knowledge Scale of the ACS Response 
Index. The mean cardiac knowledge score for the entire sample on the ACS Response 
Index was 71% (SD 12%) with a range of 8 to 100%.  Characteristics associated with 
higher knowledge scores were female gender, participation in a formal cardiac 
rehabilitation program, higher levels of education, younger age, and medical care by a 
cardiologist (compared to a family practitioner or internist) as summarized in Table 2.  
Clinical history such as previous AMI, cardiac surgery or percutaneous coronary 
intervention made no significant difference in knowledge level. Documented cardiac risk 
factors (i.e., being a current smoker or having hypercholesterolemia) were also not 
significant predictors of knowledge about ACS.  
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 Gender is an important predictor of clinical outcome in ACS, with women having 
significantly higher mortality following AMI14 and longer prehospital delay to treatment 
of an ACS.16  Given that one of the most powerful predictors of knowledge in our sample 
was gender, with women significantly more likely to score >70% on the Knowledge 
Scale than men (O.R. 1.77, p<0.000), we further examined differences between men and 
women in cardiac knowledge. Overall knowledge scores were higher for women than 
men (73% vs. 70%).  Women more accurately identified less typical symptoms of AMI 
than men (back pain, jaw pain, heartburn, nausea, and neck pain).  Fewer men than 
women knew that heart disease was the most common cause of death in women. More 
men than women stated their preference for someone to drive them to the hospital if they 
experienced AMI symptoms rather than go by ambulance. (Table 3). 
 In this group of patients, who were all at significant risk for a future AMI, 43% 
inappropriately assessed their risk as less than or the same as other people their age. More 
men than women perceived themselves as being at low risk (47% vs, 36% respectively). 
Yet, men were significantly more confident that they would recognize signs/symptoms of 
an AMI in themselves or others compared to women, despite the fact that they knew less 
about symptoms of AMI than women. Patients were most likely to identify themselves at 
“low risk” for a future AMI in the next five years if they had coronary bypass surgery or 
were younger in age. Patients who were female, had higher scores on the Knowledge 
Scale, were current smokers, had a history of AMI or angioplasty, and had 
hypercholesterolemia were significantly less likely to describe themselves as being at low 
risk for a future AMI. Patients were not significantly different in their assessment of risk 
by virtue of their participation in cardiac rehabilitation, receiving care from a cardiologist 
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rather than an internist, or having a higher level of formal education (Table 4).  We 
evaluated patients’ attitude about calling the EMS when experiencing symptoms of an 
ACS; 69% said they would call EMS, while 31% would choose private transportation.  
Discussion 
 Where do patients who are diagnosed with ACS obtain their health information? 
In decades past, such patients were frequently hospitalized and would receive education 
and counseling from physicians and nurses during their hospital stay. Unfortunately, 
structural changes in health care delivery have led to decreased lengths of hospital stay 
and increased use of outpatient facilities for cardiac diagnosis and treatment, which in 
turn have had a dramatic effect on the time available for the education of patients with 
ACS. In a recent study of the discharge education given to heart failure patients, only 
54% received the instructions comprising the Joint Commission (TJC) process-of-care 
measure.17 This percentage was achieved given the impetus of TJC standards and it is 
likely that the percentage for non-mandated discharge education is much lower. Thus, 
there is an increasing onus on physicians to insure that patients who are at high risk for a 
future AMI are knowledgeable about ACS symptom presentation and that these patients 
understand the importance of responding quickly to cardiac symptoms to optimize 
survival and treatment outcomes.  
 Our study is the first large-scale, international study conducted to assess the 
knowledge of patients with documented ACS about their disease and its symptoms. 
Given that individuals with coronary heart disease have a five to seven times greater risk 
of AMI or death than the general population,18 we also assessed their sense of perceived 
risk for a future AMI with the assumption that a heightened sense of perceived risk may 
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contribute to quicker action to seek treatment at the onset of symptoms and reduced 
prehospital delay time. Physicians and other health professionals might appropriately 
believe that this group of high-risk patients will be knowledgeable about the actions to 
take in the face of new ACS symptoms and will act quickly to access the emergency 
medical system. However, numerous investigators have documented that patients who 
have experienced an AMI in the past have prehospital delay times that are not 
significantly different than patients with no history of AMI.7,19  Given the relatively low 
level of knowledge in this high-risk population, it is perhaps not surprising that persons 
with a previous history of AMI are not more likely to recognize AMI symptoms and seek 
treatment early when compared to previously healthy individuals. 19 
 Our findings about what patients with documented heart disease know about the 
symptoms of AMI and appropriate actions to take, as well as their perceived risk of 
vulnerability for a future AMI, provide important insights into this phenomenon that is 
counterintuitive for clinicians. Their knowledge about heart disease was relatively low 
and perceptions of personal risk lower than expected in this high-risk group with a history 
of heart disease. In an attempt to identify which patients in clinical practice may need 
extra attention by physicians in medical follow-up visits, we identified characteristics 
associated with higher and lower levels of knowledge about heart diseases. Gender, age 
and education were all significant predictors of knowledge, with male sex, older age, and 
less formal education associated with less knowledge. 
 The findings about gender were particularly surprising, because women have 
often underestimated their risk for heart disease in years past20,21 and have had longer pre-
hospital delay times than men,22,23 suggesting a lack of knowledge about AMI symptoms 
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or a lack of appreciation for the importance of heart disease as a cause of death in 
women. In recent large community samples of healthy individuals, gender made no 
difference in knowledge about heart disease and its symptoms,24,25 findings that are in 
direct contrast to the findings in the current study. In our study that included only people 
with known coronary artery disease, we found that women were more knowledgeable 
than men about ACS symptoms and more likely to see themselves at higher risk than age-
matched healthy controls.  
 The findings related to gender differences suggest that physician counseling of 
female patients, coupled with a number of community-based, public education programs 
conducted over the past decade by the federal government and organizations such as the 
American Heart Association and the National Heart Foundation of Australia have had a 
positive effect. Some of the campaigns such as the American Heart Association’s “Go 
Red” and the National Heart, Lung, and Blood Institute's "Heart Truth" campaign have 
focused specifically on women to alert them to their risk for heart disease, and our 
findings support recent evidence that such campaigns have had a positive effect.21 We 
found that women were more likely than men to identify less well appreciated symptoms 
of AMI and were more likely to identify the appropriate actions to take in the face of new 
AMI symptoms. Compared to men, women were significantly more likely to know about 
the possibility of reperfusion therapy and the need to call the Emergency Medical System 
(EMS) rather than drive themselves to the hospital. Other investigators have found that 
the majority of information for women about ACS symptoms comes from the media,25 
suggesting that the recent media campaigns have been successful in raising women’s 
level of knowledge and sense of perceived risk. 
 12
 Two other clinical variables were associated with higher levels of knowledge; 
namely, being under the care of a cardiologist and having attended a cardiac 
rehabilitation program. Both underscore the importance of specialty care for patients with 
heart disease, findings that are well supported in previous studies of clinical outcomes. 
For example, patients with heart disease who are seen by cardiologists rather than 
generalists for their care are more likely to receive care recommended in clinical 
guidelines and more likely to have positive clinical outcomes.26 
 Although not yet documented, a perceived sense of vulnerability to a future AMI 
may be helpful in getting patients to pay attention to cardiac symptoms when they occur 
and to seek treatment promptly by calling EMS. Patients were more likely to feel at 
appropriately high risk if they were older, a current smoker, and had a history of AMI, 
angioplasty or hypercholesterolemia, all of them highly accurate perceptions given 
epidemiological data about cardiac risk factors.  Higher levels of knowledge were also 
associated with higher levels of perceived risk, suggesting that instruction about ACS 
symptoms and steps to take in an emergency may influence patients’ understanding of 
their vulnerability for a future heart attack. This inverse relationship of knowledge and 
perceived risk suggests that the lower levels of knowledge about ACS documented in 
men compared to women underscores the need for continuing reinforcement of the 
information in physician-patient encounters. A sense of perceived risk or vulnerability 
may decrease prehospital delay to treatment, although this association awaits further 
study. 
 In summary, knowledge about ACS symptoms and correct actions to take in 
seeking care is required for appropriate self care. Physicians can identify patients who are 
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less likely to have necessary knowledge and an appreciation of their high risk status and 
provide extra education and counseling. Our findings suggest that men, the elderly, those 
with low levels of education and those who have not attended a cardiac rehabilitation 
program are more likely to require special efforts during medical office visits to review 
symptoms of AMI and to learn the appropriate actions to take in the face of new 
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Table 1. Demographic and Clinical Characteristics of Patients at Risk for an Acute 
Coronary Syndrome (N=3522) 
Characteristic Percentage (Number) 






25%       (884) 
31%     (1092) 
32%     (1127) 
12%       (417) 
Male 68%      (2393) 
Country 
 United States 
 Australia/New Zealand 
 
56%     (1985) 









91.0%     (3207) 
  3.6%      (126) 
  1.8%        (62)  
  1.2%        (42) 
  0.9%        (33) 
  1.5%        (52) 
Marital status 
Married or living with significant other 
 
70%        (2468) 
Education  
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Less than high school 
High school 
Some college, technical training, other 
College, graduate school or higher 
15.8%       (557) 
18.2%       (641) 
37.7%      (1326)  
28.3%       (994) 
Medical history 
History of angina 
History of myocardial infarction 
History of prior cardiac surgery 
History of prior coronary angioplasty 
History of current smoking 
History of cardiac rehabilitation 
 
60.1%      (2056) 
55.2%      (1894) 
46.0%      (1618) 
47.9%      (1666) 
6.5%          (227) 
52.5%      (1763) 
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Table 2.  Patient characteristics associated with high levels of knowledge about acute 
coronary syndrome (>70% correct), N=3176  
Characteristic Odds Ratio Lower 95% C.I. Higher 95% C.I. P value 
Gender – female 1.77 1.50 2.08 0.000 
Cardiac 
Rehabilitation 
1.49 1.28 1.73 0.000 
Education §    0.000 
Education – High school graduate 1.38 1.08 1.77 0.010 
Education – Some 
college/technical 
1.21  .97  1.50 0.086 
Education – college graduate 1.78 1.41 2.24 0.000 
Age #    0.000 
<60 years 2.62 2.01 3.41 0.000 
60-69 years 2.31 1.79 2.98 0.000 
70-79 years 1.68 1.31 2.16 0.000 
Cardiologist 1.34 1.10 1.64 0.004 
History of PTCA 1.11   .95 1.30 0.197 
History of CABG 1.08   .92 1.26 0.375 
History of MI 1.09   .94 1.27 0.238 
Hypercholestrolemia 1.03   .88 1.20 0.704 
Current smoker 1.05   .77 1.43 0.763 
 
 21
C.I. = Confidence Interval; CABG = coronary artery bypass grafting; MI = myocardial 
infarction; PTCA percutaneous transluminal coronary angioplasty; 
§ All levels of education compared to “less than high school diploma” 
# All age categories compared to >80 years 
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Table 3.  Differences in correct responses about an acute coronary syndrome by gender  







Women rarely have  
HA§ 
Disagree 89.1% (2133) 94.6%  (1067) 0.001 
Should wait with  
symptoms to be sure 
Disagree  84.1%  (2013) 77.8%    (878) 0.001 
If having HA, have 
another person drive 
 you to the hospital  
rather than call EMS# 
Disagree  67.3%  (1610) 72.3%  (815) 0.003 
Hospitals have drugs 
to reduce HA damage 
Agree 73.8%  (1762) 78.9% (890) 
 
0.001 
CHD most common 














Table 4.  Demographic and clinical characteristics associated with perceived moderate to 
high risk for future acute myocardial infarction (N=3149) 
Characteristic Odds Ratio Lower 95% C.I.  Upper 95% C.I. P value 
Gender – female   1.62 1.37 1.69 0.000 
Cardiac knowledge - 
high 
  1. 45 1.69 1.908 0.000 
History of MI   1.50 1.30 1.74 0.000 
History of CABG   0.79 0.67 0.92 0.003 
Age #    0.003 
      <60 years   0.99 0.756 1.29 0.933 
       60-69 years  0.75 0.97 1.731 0.025 
       70-79 years  0.73 0.57 0.946 0.017 
Current smoker  1.47 1.06 2.03 0.020 
Hypercholesterolemia  1.19 1.02 1.39 0.026 
History of PTCA  1.17 1.00 1.37 0.047 
Cardiac rehabilitation  0.90 0.76 1.04 0.135 
Care by cardiologist  1.21 0.99 1.47 0.066 
Education§    0.069 
      HS diploma 0.81 0.63 1.04 0.103 
      Some college 0.93 0.75 1.16 0.523 
      College graduate 1.09 0.86 1.37 0.482 
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CI = confidence interval; CABG = coronary artery bypass grafting; MI = myocardial 
infarction; PTCA = percutaneous transluminal coronary angioplasty; 
§ All levels of education compared to “less than high school diploma” 
# All age categories compared to >80 years 
 
